Orthofix Medical Inc

Orthofix Medical Inc. (NASDAQ: OFIX) is a global medical technology company focused on advancing healing and restoring mobility for patients with complex musculoskeletal conditions. The company operates as the only musculoskeletal pure-play spanning spine, bone stimulation, biologics, limb reconstruction, and zero-radiation navigation. Its portfolio includes spinal implants and fixation systems, the 7D FLASH Navigation System (the world's only zero-radiation spine image-guided surgery system), therapeutic solutions including bone growth stimulators (marketed under AccelStim, SpinalStim, PhysioStim, and CervicalStim brands), biologics products (Trinity Elite cellular allograft, OsteoStrand Plus DBM, OsteoCove synthetic), and limb reconstruction systems (TL-HEX, Fitbone, TrueLok Elevate). The company addresses an approximately $16 billion total addressable market across spinal implants (~$10.1B), limb reconstruction (~$2.6B), biologics (~$2.1B), therapeutic solutions (~$0.6B), and enabling technologies (~$0.4B). Orthofix holds the #1 market position in bone growth stimulation with over 1.4 million devices prescribed, the #2 position in cellular allograft, and the #3 position in demineralized bone matrix. The company generates approximately $829 million in trailing twelve-month pro forma net sales and employs a Voyager earnout program that drives recurring implant pull-through from 7D FLASH system placements. Updated Aug 5, 2026